Pharma Stocks on Notice as US FDA Inspections Raise Concerns

Caplin Point Laboratories, a pharmaceutical company, has been inspected by the US FDA at its subsidiary's manufacturing facility in Gummidipoondi, Tamil Nadu. The inspection was unannounced, and the details of any findings have not been released yet.

Federal Bank has announced plans to raise up to $500 million through foreign currency-denominated bonds via its IFSC Banking Unit at GIFT City. This move is aimed at expanding the bank's international presence.

Manipal Health Enterprises reported a decline in consolidated net profit, despite a strong growth in revenue and operating performance. The company saw a 7.48% decrease in net profit to Rs 231.65 crore in Q1 FY27 from Rs 250.37 crore in Q1 FY26.

NATCO Pharma has received four observations from the US FDA post an inspection at its manufacturing plant in Visakhapatnam. The company will need to address these issues to avoid any regulatory action.